Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
18 Cards in this Set
- Front
- Back
What are the main indications for intervention in acute HBV?
|
failure of synthetic function of liver
-lamivudine used in RCT |
|
1st thing to check in management of chronic Hep B?
|
HBeAg
|
|
If HBeAg is positive, what 2 measures could direct you to treat?
|
HBV DNA >20,000 IU/ml
and ALT elevation |
|
At what measures should you give no tx for HBeAg positive folks?
|
HBV <20,000 IU/ml
|
|
If someone presents with HBV DNA >20,000 IU/ml (HBeAg+) or HBV DNA >2,000IU/ml (HBeAg-) and normal ALTs, what are the next steps?
|
monitor ALT levels
consider biopsy have to keep on long-term tx, so consider factors. |
|
HBV DNA detectable by PCR in decompensated cirrhosis?
|
treat w/ oral agents, combo therapy
no IFN |
|
3 good options for suppressing chronic HBV
|
entecavir
tenofovir telbivudine |
|
All oral nucleosides contain a black box warning for what?
|
lactic acidosis
|
|
Patients to tx with HCV
|
adults
HCV RNA detectable in serum compensated liver disease (IFN contraindicated otherwise) |
|
sustained virologic response means what?
|
cure of HCV
|
|
Rapid virologic response is what?
|
virus negative at week 4
|
|
Current tx for genotype 1 in HCV
|
ribavirin, IFN, protease inhibitor (telaprevir or boceprevir)
|
|
IFN side effects
|
depression
blood dyscrasias thyroid disorders fatigue/flu-like |
|
RBV side effects
|
anemia
|
|
Telaprevir side effects
|
rash, anorectal symptoms
|
|
Bocepravir side effects
|
anemia
dysgeusia |
|
Population more at risk for anemia
|
higher starting Hbg, age, reduced CrCl
RBV dose reduction, EPO therapy |
|
Genetic polymorphism that demonstrates inc tx response
|
IL28B
CC/CT/TT greatest in East Asians |